Concerns: ______________________ Date of birth:

First Page		Document Content
Date: 2014-04-21 10:43:16 Sodium channel blockers Medicine Amines Alcohols Brugada syndrome Syndromes Lidocaine Flecainide Analgesic Chemistry Antiarrhythmic agents Organic chemistry		Concerns: ______________________ Date of birth: Add to Reading List Source URL: www.brugadadrugs.org Download Document from Source Website File Size: 60,72 KB Share Document on Facebook

	Beilage 1: Arzneimittelmonographien DocID: 1rinj - View Document
	Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform DocID: 1reFq - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM. --------------------- DOSAGE FO DocID: 1rcHl - View Document
	Strensiq, INN-asfotase alfa DocID: 1rcrc - View Document
	Microsoft Word - CINRYZE.Product Monographdoc DocID: 1qE2h - View Document